Federal coverage of COVID drugs is ending

COVID-19 treatments, including Pfizer's Paxlovid, will begin transitioning to the commercial market this week, with costs of the drugs set to increase. Why it matters: The oral antivirals reduce the risk of hospitalization or death from COVID-19 and until now have been free for patients through…#pfizer #merck #medicare #medicaid #indianhealthservice #departmentofdefense #xavierbecerra
Source: Reuters: Health - Category: Consumer Health News Source Type: news